The Food & Drug Administration (FDA) in the Union Territory of Pondicherry has granted licence to Chennai-based Ramoni Research Foundation (RRF), an institute conducting research in Ayurveda medicines, to manufacture and market an Ayurvedic antiviral medication Ayusrem, which is a potential drug to prevent and treat H1N1.
The scientists at the foundation claimed that the drug is a potential choice to prevent and treat H1N1 flu and will prove to be a boon to the people as it is being launched at a time when the entire world is stepping up efforts to tackle the H1N1 pandemic. According to the scientists, the drug is made of extracts from anti-viral plants and antipyretic plants like Andrographis paniculata, Curcuma Longa and Vetiveria zizanioides. Extracts of Immunomodulant plants like Zingiber officinale and Piper nigrum have also been included. The Analgesic ingredients in the formulation are from Andrographis paniculata, Zingiber officinale and Cyperus rotundus.
Claiming that the herbal product can contain the spread of swine flu and other strains of viruses, RRF has written to the Department of Ayush to take measures to evaluate the effect of medicinal plants and formulations for antiviral activity. The letter says that the potential of medicinal plants is well known for their antiviral activity and the Herbal Sciences Department of the Madras University has initiated several studies on it. The Centre has generated scientific data on 130 plants so far, which will help millions of sufferers of virus diseases, the scientists told Pharmabiz.
The foundation hopes that the permission by the FDA will reap results in a way that it will help RRF to penetrate into the huge Indian Ayurvedic market and the growing global market of Ayurvedic products when viral diseases are spreading alarmingly and taking lives across the world. RRF’s Ayusrem is the outcome of a joint venture with the Herbal Science Research Centre of Madras University.
The scientists in the foundation said FDA in Pondicherry is the first regulatory authority to certify and approve the drug for sales after its invention by Chennai based institutes six months ago. The inventors of the remedy have claimed that within this short span of time, the medicine could cure various kinds of viral diseases of about 2000 people including those affected with A H1N1 viruses.
RRF has invented the medicine Ayusrem, after years of researches associating with the Centre for Herbal Sciences at the University of Madras. When the drug was launched in September last year, it was a formulation of Ayurveda and Siddha preparations. Later, the formulation was completely restricted in Ayurvedic method only, said the inventors of the product, Dr K Balasubrahmaniam and professor Dr A Raaman.
Last week, in a function organized in Pondicherry Lt Governor Dr Iqbal Singh inaugurated the official launching of the medicine by handing over a strip of 10 tablets of Ayusrem to the Health & Family Welfare Minister E Valasaraj. Public health minister A Namasivayam was also present on the occasion.
After the invention of Ayusrem, Ramoni Research Foundation has bagged three Awards of Excellence. National Citizen Excellence Award from Intellectual People and Economic Growth Association, New Delhi for Outstanding Contribution, International Achievers Award for invention of Ayusrem by International Achievers Forum, Thailand, and Bharath Gaurav Award from India International Friendship Society for meritorious services.
D Balasubrahmaniam, the chairman of the foundation said RRF has signed an agreement with Pondicherry based Dr Milton’s Laboratories to manufacture the drug and inked another contract with Chennai-based Berjayaa Marketing Private Ltd for domestic marketing. They have also signed certain pacts with Leonex Systems of Malaysia to market the Ayurvedic antiviral remedy.